openalexFrontiers in Oncology2026-07-24
Autoimmune GFAP astrocytopathy associated with sintilimab immunotherapy in a patient with esophageal squamous cell carcinoma: a case report and literature review
Yajie Fan, Yaxuan Yao, Xutao Guan, Shansi Zou, Menghua Li, Qilong Gao, et al.
Esophageal squamous cell carcinoma (ESCC) is a highly lethal malignant tumor. Immune checkpoint inhibitors (ICIs), represented by sintilimab, have become an important treatment option for advanced ESCC, but they may induce immune-related adverse events (irAEs) involving multiple…